Therapeutic Asset Ratings
271 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Genetically Engineered Ny-Eso-1-Specific T Lymphocytes
Ovarian Carcinoma
Roswell Park Cancer Institute
P1
CC
(41)
Genetically Engineered Ny-Eso-1-Specific T Lymphocytes
Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P1
CC
(41)
Talzenna
Colorectal Adenocarcinoma
Roswell Park Cancer Institute
P1
CC
(41)
TIPIRACIL
Advanced Malignant Solid Neoplasm
Roswell Park Cancer Institute
P1
CC
(41)
Trifluridine
Advanced Malignant Solid Neoplasm
Roswell Park Cancer Institute
P1
CC
(41)
Carfilzomib
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Roswell Park Cancer Institute
P1
C
(39)
Cedazuridine
Castration-Resistant Prostate Carcinoma
Roswell Park Cancer Institute
P1
C
(39)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Roswell Park Cancer Institute
P1
C
(39)
Recombinant Human EGF-rP64K
Colorectal Cancer
Roswell Park Cancer Institute
Early P1
C
(39)
Binimetinib
Lung Adenocarcinoma
Roswell Park Cancer Institute
Early P1
C
(38)
Palbociclib
Lung Adenocarcinoma
Roswell Park Cancer Institute
Early P1
C
(38)
Alpha-Type-1 Polarized Dendritic Cells
Breast Cancer
Roswell Park Cancer Institute
P2
C
(37)
Alpha-Type-1 Polarized Dendritic Cells
HLA-A2 Positive Cells Present
Roswell Park Cancer Institute
P2
C
(37)
Alpha-Type-1 Polarized Dendritic Cells
Triple-Negative Breast Carcinoma
Roswell Park Cancer Institute
P2
C
(37)
Alpha-Type-1 Polarized Dendritic Cells
Melanoma
Roswell Park Cancer Institute
P2
C
(37)
Alpha-Type-1 Polarized Dendritic Cells
Fallopian Tube Cancer
Roswell Park Cancer Institute
P1/2
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Ovarian Cancer
Roswell Park Cancer Institute
P1/2
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P1/2
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Ovarian Carcinoma
Roswell Park Cancer Institute
P1/2
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P1/2
C
(34)
PROPRANOLOL
Smoldering Plasma Cell Myeloma
Roswell Park Cancer Institute
N/A
D
(30)
Showing 251 to 271 of 271 assets
Previous
Page 11 of 11
Next